LENZ Therapeutics, Inc. (NASDAQ: LENZ) reported Q3 EPS of ($0.99), $0.08 worse than the analyst estimate of ($0.91). Revenue for the quarter came in at $3.38 million versus the consensus estimate of $4.5 million.

For earnings history and earnings-related data on LENZ Therapeutics, Inc. (LENZ) click here.